Cellular senescence and SASP in tumor progression and therapeutic opportunities
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
Cellular senescence (CS), a permanent and irreversible arrest of the cell cycle and proliferation leading to the degeneration of cellular structure and function, has been implicated in various key physiological and pathological processes, particularly in cancer. Initially, CS was recognized as a barrier to tumorigenesis, serving as an intrinsic defense mechanism to protect cells from malignant transformation. However, increasing evidence suggests that senescent cells can promote tumor progression to overt malignancy, primarily through a set of factors known as senescence-associated secretory phenotypes (SASPs), including chemokines, growth factors, cytokines, and stromal metalloproteinases. These factors significantly reshape the tumor microenvironment (TME), enabling tumors to evade immune destruction. Interestingly, some studies have also suggested that SASPs may impede tumor development by enhancing immunosurveillance. These opposing roles highlight the complexity and heterogeneity of CS and SASPs in diverse cancers. Consequently, there has been growing interest in pharmacological interventions targeting CS or SASPs in cancer therapy, such as senolytics and senomorphics, to either promote the clearance of senescent cells or mitigate the harmful effects of SASPs. In this review, we will interpret the concept of CS, delve into the role of SASPs in reshaping the TME, and summarize recent advances in anti-tumor strategies targeting CS or SASPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–210 of 210
Autocrine IL-1β mediates the promotion of corneal neovascularization by senescent fibroblasts
Dong, M., Yang, L., Qu, M., Hu, X., Duan, H., Zhang, X., Shi, W., & Zhou, Q. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00205.2017 · Cited by 17
A Fresh Approach to Targeting Aging Cells: CAR-T Cells Enhance Senolytic Specificity
Li, J. H., & Chen, Y. Y. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.07.010 · Cited by 17
Kim, Y., Ji, H., Cho, E., Park, N. H., Hwang, K., Park, W.-S., Lee, K.-S., Park, D., & Jung, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413673 · Cited by 17
Vickridge, E., Faraco, C. C. F., Samavarchi‐Tehrani, P., Ramdzan, Z. M., Djerir, B., Rahimian, H., Leduy, L., Maréchal, A., Gingras, A., & Nepveu, A. (2022) · NAR Cancer · doi:10.1093/narcan/zcac028 · Cited by 17
Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest
Rossi, M. S., Anerillas, C., Idda, M. L., Munk, R. B., Shin, C. H., Donegà, S., Tsitsipatis, D., Herman, A. B., Martindale, J. L., Yang, X., et al. (2023) · eLife · doi:10.7554/elife.84238 · Cited by 17
Selective Elimination of Senescent Fibroblasts by Targeting the Cell Surface Protein ACKR3
Takaya, K., Asou, T., & Kishi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126531 · Cited by 16
Kim, S. Y., Yang, E. J., Lee, S. B., Lee, Y., Cho, K. A., & Park, S. C. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00490-x · Cited by 15
A novel role for YPEL2 in mediating endothelial cellular senescence via the p53/p21 pathway
Xu, J., Tang, M.-L., Lu, Z.-F., Song, Y., Zhang, K., He, R.-C., Guo, X., Yuan, Y.-Q., Dai, X., & Ma, X. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111803 · Cited by 14
Park, M., Na, J., Kwak, S. Y., Park, S., Kim, H., Lee, S., Jang, W., Lee, S. B., Jang, W. I., Jang, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158390 · Cited by 13
Chen, X., Li, Y., Zhou, Z., Zhang, Y., Chang, L., Gao, X., Li, Q., Luo, H., Westover, K. D., Zhu, J., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6607 · Cited by 8
Cited by
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Alum, E., Izah, S., Uti, D., Ugwu, O., Betiang, P., Basajja, M., & Ejemot-Nwadiaro, R. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s543211 · Cited by 63
Wu, J., Zhang, L., Zhao, Z., Liu, Y., Li, Z., Feng, X., Zhang, L., Yao, X., Du, J., Chen, L., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102783 · Cited by 10
Bar, S., Hilsabeck, T. A. U., Pattavina, B., López-Domínguez, J. A., Basisty, N., Bons, J., Watson, M., Schilling, B., Campisi, J., Kapahi, P., et al. (2025) · Aging · doi:10.18632/aging.206224 · Cited by 3
Metadata
- Authors
- Dong, Z., Luo, Y., Yuan, Z., Tian, Y., Jin, T., & Xu, F.
- Venue
- Molecular Cancer
- Published
- 2024-08-31
- Volume
- 23
- Issue
- 1
- Pages
- 181-181
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W4402081779
- Cited by
- 259
- References
- 210
- FWCI
- 61.02
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.